Malaguarnera M |
Carnitine derivatives: clinical usefulness. |
2012 |
Curr. Opin. Gastroenterol. |
pmid:22333562
|
Kasahara M et al. |
Living-donor liver transplantation for propionic acidemia. |
2012 |
Pediatr Transplant |
pmid:22151065
|
Hiatt WR et al. |
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. |
2011 Mar-Apr |
J Cardiopulm Rehabil Prev |
pmid:20861750
|
Sarafoglou K et al. |
Expanded newborn screening for detection of vitamin B12 deficiency. |
2011 |
JAMA |
pmid:21427371
|
Mingorance C et al. |
Pharmacological effects and clinical applications of propionyl-L-carnitine. |
2011 |
Nutr. Rev. |
pmid:21521230
|
Mingorance C et al. |
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. |
2011 |
Vasc Health Risk Manag |
pmid:21490942
|
Hozyasz KK et al. |
Whole blood propionylcarnitine in newborns with orofacial cleft. |
2011 |
Matern Child Nutr |
pmid:21470367
|
Laviano A et al. |
Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats. |
2011 |
Cancer Invest. |
pmid:22085273
|
Wagner CC et al. |
Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation. |
2011 |
Xenobiotica |
pmid:21810044
|
Mikhailova TL et al. |
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21929562
|